Association between serum creatinine to cystatin C ratio and incident asthma in community-dwelling middle-aged and older adults: a prospective cohort study from CHARLS

The serum creatinine-to-cystatin C ratio (Scr/CysC) has drawn interest as a possible marker of muscle mass and metabolic health, but its relationship with new-onset asthma in older adults remains unclear. We used the China Health and Retirement Longitudinal Study (CHARLS) to examine this question and to generate hypotheses for future research. We used the 2011–2012 CHARLS baseline and follow-up waves 2–5 (2013, 2015, 2018, and 2020). Adults aged at least 45 years and free of asthma at baseline were eligible. The full eligible cohort included 7,994 participants; time-to-event analyses included 7,864 after 130 participants without a usable censoring time were excluded. Fine-Gray models with death as a competing risk served as the primary analysis, with cause-specific Cox models as supportive time-to-event analyses. Logistic and Poisson models were restricted to the complete-outcome cohort ( n = 5,443). We also performed a cause-specific Cox restricted cubic spline, subgroup analysis, eGFR adjustment, and inverse-probability-of-censoring weighted analysis. Among the 7,864 participants with a usable censoring time, mean (SD) follow-up was 8.12 (1.90) years, and 459 participants developed asthma. In Model 2, each 1-SD increase in the Scr/CysC ratio corresponded to a Fine-Gray SHR of 0.926 (95% CI 0.834–1.029; P = 0.154); cause-specific Cox estimates pointed in the same direction but were not statistically significant. In the complete-outcome cohort, the Fine-Gray SHR was 0.867 (95% CI 0.776–0.968; P = 0.011). The 4-knot cause-specific Cox restricted cubic spline showed no strong evidence of nonlinearity ( P = 0.173). We did not find a statistically significant association in the full eligible cohort. The complete-outcome sensitivity analysis showed a directionally consistent signal, but this finding should be viewed as hypothesis-generating. Confirmation will require studies with repeated Scr/CysC measurements and objectively ascertained asthma outcomes.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2026-11-13
DOI
https://doi.org/10.1186/s12889-026-30188-0
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between serum creatinine to cystatin C ratio and incident asthma in community-dwelling middle-aged and older adults: a prospective cohort study from CHARLS

Cheng Song, Jixiang Ni, Jing Zhu, Xiaoxiao Xu
5 links
BMC Public Health
Asthma and respiratory diseases
article

Association between serum creatinine to cystatin C ratio and incident asthma in community-dwelling middle-aged and older adults: a prospective cohort study from CHARLS

Cheng Song, Jixiang Ni, Jing Zhu, Xiaoxiao Xu
article en

Abstract

The serum creatinine-to-cystatin C ratio (Scr/CysC) has drawn interest as a possible marker of muscle mass and metabolic health, but its relationship with new-onset asthma in older adults remains unclear. We used the China Health and Retirement Longitudinal Study (CHARLS) to examine this question and to generate hypotheses for future research. We used the 2011–2012 CHARLS baseline and follow-up waves 2–5 (2013, 2015, 2018, and 2020). Adults aged at least 45 years and free of asthma at baseline were eligible. The full eligible cohort included 7,994 participants; time-to-event analyses included 7,864 after 130 participants without a usable censoring time were excluded. Fine-Gray models with death as a competing risk served as the primary analysis, with cause-specific Cox models as supportive time-to-event analyses. Logistic and Poisson models were restricted to the complete-outcome cohort ( n = 5,443). We also performed a cause-specific Cox restricted cubic spline, subgroup analysis, eGFR adjustment, and inverse-probability-of-censoring weighted analysis. Among the 7,864 participants with a usable censoring time, mean (SD) follow-up was 8.12 (1.90) years, and 459 participants developed asthma. In Model 2, each 1-SD increase in the Scr/CysC ratio corresponded to a Fine-Gray SHR of 0.926 (95% CI 0.834–1.029; P = 0.154); cause-specific Cox estimates pointed in the same direction but were not statistically significant. In the complete-outcome cohort, the Fine-Gray SHR was 0.867 (95% CI 0.776–0.968; P = 0.011). The 4-knot cause-specific Cox restricted cubic spline showed no strong evidence of nonlinearity ( P = 0.173). We did not find a statistically significant association in the full eligible cohort. The complete-outcome sensitivity analysis showed a directionally consistent signal, but this finding should be viewed as hypothesis-generating. Confirmation will require studies with repeated Scr/CysC measurements and objectively ascertained asthma outcomes.

BMC Public Health
Central Hospital of Wuhan (CN), Huazhong University of Science and Technology (CN)
Good health and well-being
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon